AC Immune SA (ACIU)
NASDAQ: ACIU
· Real-Time Price · USD
1.93
-0.01 (-0.52%)
At close: Jun 17, 2025, 3:59 PM
1.92
-0.52%
After-hours: Jun 17, 2025, 04:04 PM EDT
-0.52% (1D)
| Bid | 1.79 |
| Market Cap | 190.96M |
| Revenue (ttm) | 28.3M |
| Net Income (ttm) | -52.08M |
| EPS (ttm) | -0.64 |
| PE Ratio (ttm) | -3.02 |
| Forward PE | -2.74 |
| Analyst | Buy |
| Ask | 2.25 |
| Volume | 55,645 |
| Avg. Volume (20D) | 150,523 |
| Open | 1.94 |
| Previous Close | 1.94 |
| Day's Range | 1.90 - 1.98 |
| 52-Week Range | 1.43 - 4.41 |
| Beta | 1.58 |
About ACIU
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ACIU
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ACIU stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts7 months ago
+13.42%
AC Immune shares are trading higher after the comp...
Unlock content with
Pro Subscription
9 months ago
+5.81%
AC Immune shares are trading higher after the company announced it will receive the second ReTain-related milestone payment under its agreement with Janssen Pharmaceuticals.
